Publications

• 1. Garrett N
  2. Dintwe O
  3. Monaco CL
  4. Jones M
  5. Seaton KE
  6. Church EC
  7. Grunenberg N
  8. Hutter J
  9. deCamp A
  10. Huang Y
  11. Lu H
  12. Mann P
  13. Robinson ST
  14. Heptinstall J
  15. Jensen RL
  16. Pantaleo G
  17. Ding S
  18. Koutsoukos M
  19. Hosseinipour MC
  20. Van Der Meeren O
  21. Gilbert PB
  22. Ferrari G
  23. Andersen-Nissen E
  24. McElrath MJ
  25. Tomaras GD
  26. Gray GE
  27. Corey L
  28. Kublin JG
  Safety and Immunogenicity of a DNA Vaccine With Subtype C gp120 Protein Adjuvanted With MF59 or AS01B: A Phase 1/2a HIV-1 Vaccine Trial.; Journal of acquired immune deficiency syndromes (1999); Vol 96(4), pp. 350-360. 2024 Jun 21.
• 1. Fisher LH
  2. Kee JJ
  3. Liu A
  4. Espinosa CM
  5. Randhawa AK
  6. Ludwig J
  7. Magaret CA
  8. Robinson ST
  9. Gilbert PB
  10. Hyrien O
  11. Kublin JG
  12. Rouphael N
  13. Falsey AR
  14. Sobieszczyk ME
  15. El Sahly HM
  16. Grinsztejn B
  17. Gray GE
  18. Kotloff KL
  19. Gay CL
  20. Leav B
  21. Hirsch I
  22. Struyf F
  23. Dunkle LM
  24. Neuzil KM
  25. Corey L
  26. Huang Y
  27. Goepfert PA
  28. Walsh SR
  29. Baden LR
  30. Janes H
  SARS-CoV-2 Viral Load in the Nasopharynx at Time of First Infection Among Unvaccinated Individuals: A Secondary Cross-Protocol Analysis of 4 Randomized Trials.; JAMA network open; Vol 7(5), pp. e2412835. 2024 May 01.
• 1. Davis EC
  2. Monaco C
  3. Insel R
  4. Järvinen KM
  Gut microbiome in the first 1000 days and risk for childhood food allergy.; Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology. 2024 Mar 15.
• 1. Rick AM
  2. Laurens MB
  3. Huang Y
  4. Yu C
  5. Martin TCS
  6. Rodriguez CA
  7. Rostad CA
  8. Maboa RM
  9. Baden LR
  10. El Sahly HM
  11. Grinsztejn B
  12. Gray GE
  13. Gay CL
  14. Gilbert PB
  15. Janes HE
  16. Kublin JG
  17. Huang Y
  18. Leav B
  19. Hirsch I
  20. Struyf F
  21. Dunkle LM
  22. Neuzil KM
  23. Corey L
  24. Goepfert PA
  25. Walsh SR
  26. Follmann D
  27. Kotloff KL
  Risk of COVID-19 after natural infection or vaccination.; EBioMedicine; Vol 96, pp. 104799. 2023 Sep 20.
• 1. Theodore DA
  2. Branche AR
  3. Zhang L
  4. Graciaa DS
  5. Choudhary M
  6. Hatlen TJ
  7. Osman R
  8. Babu TM
  9. Robinson ST
  10. Gilbert PB
  11. Follmann D
  12. Janes H
  13. Kublin JG
  14. Baden LR
  15. Goepfert P
  16. Gray GE
  17. Grinsztejn B
  18. Kotloff KL
  19. Gay CL
  20. Leav B
  21. Miller J
  22. Hirsch I
  23. Sadoff J
  24. Dunkle LM
  25. Neuzil KM
  26. Corey L
  27. Falsey AR
  28. El Sahly HM
  29. Sobieszczyk ME
  30. Huang Y
  Clinical and Demographic Factors Associated With COVID-19, Severe COVID-19, and SARS-CoV-2 Infection in Adults: A Secondary Cross-Protocol Analysis of 4 Randomized Clinical Trials.; JAMA network open; Vol 6(7), pp. e2323349. 2023 Jul 03.
• 1. Goodkin K
  2. Evering TH
  3. Anderson AM
  4. Ragin A
  5. Monaco CL
  6. Gavegnano C
  7. Avery RJ
  8. Rourke SB
  9. Cysique LA
  10. Brew BJ
  The comorbidity of depression and neurocognitive disorder in persons with HIV infection: call for investigation and treatment.; Frontiers in cellular neuroscience; Vol 17, pp. 1130938. 2023 Apr 28.
• 1. Monaco CL
  HIV, AIDS, and the virome: Gut reactions.; Cell host & microbe; Vol 30(4). 2022 Apr 13.
• 1. Madere FS
  2. Sohn M
  3. Winbush AK
  4. Barr B
  5. Grier A
  6. Palumbo C
  7. Java J
  8. Meiring T
  9. Williamson AL
  10. Bekker LG
  11. Adler DH
  12. Monaco CL
  Transkingdom Analysis of the Female Reproductive Tract Reveals Bacteriophages form Communities.; Viruses; Vol 14(2). 2022 Feb 19.
• 1. Madere FS
  2. Monaco CL
  The female reproductive tract virome: understanding the dynamic role of viruses in gynecological health and disease.; Current opinion in virology; Vol 52. 2022 Feb.
• 1. Falsey AR
  2. Sobieszczyk ME
  3. Hirsch I
  4. Sproule S
  5. Robb ML
  6. Corey L
  7. Neuzil KM
  8. Hahn W
  9. Hunt J
  10. Mulligan MJ
  11. McEvoy C
  12. DeJesus E
  13. Hassman M
  14. Little SJ
  15. Pahud BA
  16. Durbin A
  17. Pickrell P
  18. Daar ES
  19. Bush L
  20. Solis J
  21. Carr QO
  22. Oyedele T
  23. Buchbinder S
  24. Cowden J
  25. Vargas SL
  26. Benavides AG
  27. Call R
  28. Keefer MC
  29. Kirkpatrick BD
  30. Pullman J
  31. Tong T
  32. Isaacs MB
  33. Benkeser D
  34. Janes HE
  35. Nason MC
  36. Green JA
  37. Kelly EJ
  38. Maaske J
  39. Mueller N
  40. Shoemaker K
  41. Takas T
  42. Marshall RP
  43. Pangalos MN
  44. Villafana T
  45. Gonzalez-Lopez A
  Phase 3 Safety and Efficacy of AZD1222 (ChAdOx1 nCoV-19) Covid-19 Vaccine.; The New England journal of medicine. 2021 Sep 29.
• 1. Corey L
  2. Gilbert PB
  3. Juraska M
  4. Montefiori DC
  5. Morris L
  6. Karuna ST
  7. Edupuganti S
  8. Mgodi NM
  9. deCamp AC
  10. Rudnicki E
  11. Huang Y
  12. Gonzales P
  13. Cabello R
  14. Orrell C
  15. Lama JR
  16. Laher F
  17. Lazarus EM
  18. Sanchez J
  19. Frank I
  20. Hinojosa J
  21. Sobieszczyk ME
  22. Marshall KE
  23. Mukwekwerere PG
  24. Makhema J
  25. Baden LR
  26. Mullins JI
  27. Williamson C
  28. Hural J
  29. McElrath MJ
  30. Bentley C
  31. Takuva S
  32. Gomez Lorenzo MM
  33. Burns DN
  34. Espy N
  35. Randhawa AK
  36. Kochar N
  37. Piwowar-Manning E
  38. Donnell DJ
  39. Sista N
  40. Andrew P
  41. Kublin JG
  42. Gray G
  43. Ledgerwood JE
  44. Mascola JR
  45. Cohen MS
  Two Randomized Trials of Neutralizing Antibodies to Prevent HIV-1 Acquisition.; The New England journal of medicine; Vol 384(11). 2021 Mar 18.
• 1. Monaco CL
  2. Kwon DS
  Next-generation Sequencing of the DNA Virome from Fecal Samples.; Bio-protocol; Vol 7(5). 2017 Mar 05.
• 1. Monaco CL
  2. Gootenberg DB
  3. Zhao G
  4. Handley SA
  5. Ghebremichael MS
  6. Lim ES
  7. Lankowski A
  8. Baldridge MT
  9. Wilen CB
  10. Flagg M
  11. Norman JM
  12. Keller BC
  13. Luévano JM
  14. Wang D
  15. Boum Y
  16. Martin JN
  17. Hunt PW
  18. Bangsberg DR
  19. Siedner MJ
  20. Kwon DS
  21. Virgin HW
  Altered Virome and Bacterial Microbiome in Human Immunodeficiency Virus-Associated Acquired Immunodeficiency Syndrome.; Cell host & microbe; Vol 19(3). 2016 Mar 09.
• 1. Handley SA
  2. Desai C
  3. Zhao G
  4. Droit L
  5. Monaco CL
  6. Schroeder AC
  7. Nkolola JP
  8. Norman ME
  9. Miller AD
  10. Wang D
  11. Barouch DH
  12. Virgin HW
  SIV Infection-Mediated Changes in Gastrointestinal Bacterial Microbiome and Virome Are Associated with Immunodeficiency and Prevented by Vaccination.; Cell host & microbe; Vol 19(3). 2016 Mar 09.
• 1. Wilen CB
  2. Monaco CL
  3. Hoppe-Bauer J
  4. Jackups R
  5. Bucelli RC
  6. Burnham CA
  Criteria for reducing unnecessary testing for herpes simplex virus, varicella-zoster virus, cytomegalovirus, and enterovirus in cerebrospinal fluid samples from adults.; Journal of clinical microbiology; Vol 53(3). 2015 Mar.
• 1. Norman JM
  2. Handley SA
  3. Baldridge MT
  4. Droit L
  5. Liu CY
  6. Keller BC
  7. Kambal A
  8. Monaco CL
  9. Zhao G
  10. Fleshner P
  11. Stappenbeck TS
  12. McGovern DP
  13. Keshavarzian A
  14. Mutlu EA
  15. Sauk J
  16. Gevers D
  17. Xavier RJ
  18. Wang D
  19. Parkes M
  20. Virgin HW
  Disease-specific alterations in the enteric virome in inflammatory bowel disease.; Cell; Vol 160(3). 2015 Jan 29.
• 1. Keller BC
  2. Johnson CL
  3. Erickson AK
  4. Gale M
  Innate immune evasion by hepatitis C virus and West Nile virus.; Cytokine & growth factor reviews; Vol 18(5-6). 2007 Oct.
• 1. Johnson CL
  2. Owen DM
  3. Gale M
  Functional and therapeutic analysis of hepatitis C virus NS3.4A protease control of antiviral immune defense.; The Journal of biological chemistry; Vol 282(14). 2007 Apr 06.
• 1. Saito T
  2. Hirai R
  3. Loo YM
  4. Owen D
  5. Johnson CL
  6. Sinha SC
  7. Akira S
  8. Fujita T
  9. Gale M
  Regulation of innate antiviral defenses through a shared repressor domain in RIG-I and LGP2.; Proceedings of the National Academy of Sciences of the United States of America; Vol 104(2). 2007 Jan 09.
• 1. Chien Y
  2. Kim S
  3. Bumeister R
  4. Loo YM
  5. Kwon SW
  6. Johnson CL
  7. Balakireva MG
  8. Romeo Y
  9. Kopelovich L
  10. Gale M
  11. Yeaman C
  12. Camonis JH
  13. Zhao Y
  14. White MA
  RalB GTPase-mediated activation of the IkappaB family kinase TBK1 couples innate immune signaling to tumor cell survival.; Cell; Vol 127(1). 2006 Oct 06.
• 1. Loo YM
  2. Owen DM
  3. Li K
  4. Erickson AK
  5. Johnson CL
  6. Fish PM
  7. Carney DS
  8. Wang T
  9. Ishida H
  10. Yoneyama M
  11. Fujita T
  12. Saito T
  13. Lee WM
  14. Hagedorn CH
  15. Lau DT
  16. Weinman SA
  17. Lemon SM
  18. Gale M
  Viral and therapeutic control of IFN-beta promoter stimulator 1 during hepatitis C virus infection.; Proceedings of the National Academy of Sciences of the United States of America; Vol 103(15). 2006 Apr 11.
• 1. Johnson CL
  2. Gale M
  CARD games between virus and host get a new player.; Trends in immunology; Vol 27(1). 2006 Jan.
• 1. Foy E
  2. Li K
  3. Sumpter R
  4. Loo YM
  5. Johnson CL
  6. Wang C
  7. Fish PM
  8. Yoneyama M
  9. Fujita T
  10. Lemon SM
  11. Gale M
  Control of antiviral defenses through hepatitis C virus disruption of retinoic acid-inducible gene-I signaling.; Proceedings of the National Academy of Sciences of the United States of America; Vol 102(8). 2005 Feb 22.
• 1. Brzostowski JA
  2. Johnson C
  3. Kimmel AR
  Galpha-mediated inhibition of developmental signal response.; Current biology : CB; Vol 12(14). 2002 Jul 23.
• 1. Henderson CW
  2. Johnson CL
  3. Lodhi SA
  4. Bilimoria SL
  Replication of Chilo iridescent virus in the cotton boll weevil, Anthonomus grandis, and development of an infectivity assay.; Archives of virology; Vol 146(4). 2001.